NSPR InspireMD Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NSPR

Price (delayed)

$0.751

Market cap

$34.91M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.62

Enterprise value

$21.73M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 6

InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common ...

Highlights
NSPR's revenue has soared by 53% year-on-year
InspireMD's EPS has increased by 24% YoY and by 13% QoQ
InspireMD's equity has soared by 56% YoY but it has decreased by 28% from the previous quarter
NSPR's quick ratio is up by 43% year-on-year but it is down by 28% since the previous quarter
NSPR's gross margin is down by 36% since the previous quarter and by 14% year-on-year
InspireMD's net income has decreased by 27% YoY and by 2.3% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.inspiremd.com
Peers: ABT MDT ISRG SYK

Key stats

What are the main financial stats of NSPR

NSPR stock price

How has the InspireMD stock price performed over time
Intraday
-1.04%
1 week
-2.47%
1 month
-16.54%
1 year
-68.71%
YTD
-57.81%
QTD
7.27%

Financial performance

How have InspireMD's revenue and profit performed over time
Revenue
$10.84M
Gross profit
$1.96M
Operating income
-$53.56M
Net income
-$52.48M
Gross margin
18.1%
Net margin
-484.1%
NSPR's revenue has soared by 53% year-on-year
NSPR's gross margin is down by 36% since the previous quarter and by 14% year-on-year
InspireMD's gross profit has decreased by 36% from the previous quarter but it has increased by 32% YoY
The operating income is down by 27% YoY and by 2.7% QoQ

Price vs fundamentals

How does NSPR's price correlate with its fundamentals

Growth

What is InspireMD's growth rate over time

Valuation

What is InspireMD stock price valuation
P/E
N/A
P/B
1.12
P/S
5.86
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2
InspireMD's EPS has increased by 24% YoY and by 13% QoQ
InspireMD's equity has soared by 56% YoY but it has decreased by 28% from the previous quarter
The price to book (P/B) is 19% lower than the last 4 quarters average of 1.4 and 13% lower than the 5-year quarterly average of 1.3
The P/S is 56% lower than the last 4 quarters average of 13.4 and 46% lower than the 5-year quarterly average of 11.0
NSPR's revenue has soared by 53% year-on-year

Efficiency

How efficient is InspireMD business performance
The ROE has grown by 18% YoY and by 3.6% from the previous quarter
InspireMD's return on sales has increased by 17% YoY but it has decreased by 2.3% QoQ
The company's return on assets rose by 14% YoY and by 2.3% QoQ
InspireMD's return on invested capital has increased by 8% YoY and by 3.4% QoQ

Dividends

What is NSPR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NSPR.

Financial health

How did InspireMD financials performed over time
NSPR's quick ratio is up by 43% year-on-year but it is down by 28% since the previous quarter
InspireMD's current ratio has increased by 35% YoY but it has decreased by 26% QoQ
NSPR's debt is 94% smaller than its equity
InspireMD's equity has soared by 56% YoY but it has decreased by 28% from the previous quarter
InspireMD's debt to equity has plunged by 50% YoY but it has increased by 20% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.